We're sunsetting PodQuest on 2025-07-28. Thank you for your support!
Export Podcast Subscriptions
cover of episode Why the U.S. Can’t Break Up with China — ft. Alice Han

Why the U.S. Can’t Break Up with China — ft. Alice Han

2025/5/15
logo of podcast Prof G Markets

Prof G Markets

AI Deep Dive AI Chapters Transcript
People
A
Alice Han
E
Ed
参与金融播客,分析和讨论金融市场趋势和变化。
S
Scott Galloway
一位结合商业洞察和个人故事的畅销书作者、教授和企业家。
Topics
Scott Galloway: 我认为特朗普在降低药品价格方面的承诺并没有被市场认真对待。制药公司通过游说政客来获取超额利润,这在美国已经成为一种商业模式。由于政治献金和监管漏洞,美国消费者为药品支付的价格远高于其他国家。美国的医疗定价不透明,监管被利益集团控制,导致消费者承担了过高的医疗费用。美国的医疗保健系统存在监管漏洞,导致医疗费用高昂,但国民健康状况却更差。市场认为特朗普的药品降价计划缺乏实际行动,只是在作秀。美国国会在控制医疗成本方面软弱无力,以至于总统的声明也无法产生实际影响。美国的监管漏洞导致医疗成本过高,损害了美国经济。将美国的医疗保健成本降低到与其他发达国家相同的水平,可以释放大量资金用于其他领域。解决医疗成本问题是提升美国经济的关键。 Ed: 我认为特朗普最初提出的“最惠国待遇”药品定价政策是正确的方向。市场对特朗普最初的药品定价政策的积极反应表明了解决药品价格问题的必要性。然而,特朗普缺乏执行力,导致药品公司不会主动降低价格。只有通过法律框架才能迫使药品公司降低价格。特朗普虽然有时有正确的直觉,但缺乏执行能力。

Deep Dive

Shownotes Transcript

Translations:
中文

Support for the show comes from Public.com. If you're serious about investing, you need to know about Public.com. That's where you can invest in everything, stocks, options, bonds, and more. And even under 6% or higher yield that you can lock in with a bond account. Visit Public.com slash PropG and get up to $10,000 when you transfer your old portfolio. That's Public.com slash PropG.

I should also disclose I am an investor in public.

Support for this show comes from Pure Leaf Iced Tea. When you find yourself in the afternoon slump, you need the right thing to make you bounce back. You need Pure Leaf Iced Tea. It's real brewed tea made in a variety of bold flavors with just the right amount of naturally occurring caffeine. You're left feeling refreshed and revitalized so you can be ready to take on what's next. The next time you need to hit the reset button, grab a Pure Leaf Iced Tea. Time for a tea break? Time for a Pure Leaf.

This episode is brought to you by WorldID. Ever missed out on concert tickets because of bots? WorldID is a digital identity that anonymously proves you are a unique human online. It's like a priority lane for humans in the age of AI. You can easily and privately prove you are a human online and access things only humans should, like event tickets, dating apps, financial services, and video games. Join millions of humans across more than 160 countries and get your free WorldID by visiting world.org.

Today's number, 7%. That's the expected year-over-year decline in tourism to the U.S. in 2025. True story, Ed. I was in Paris and saw a mime and he began masturbating. Later, I heard that he was arrested, but he came quietly. 977, no me diga no, no lo que sienta.

I like that one. It's okay. Just okay? Just okay. Oh my God, it's getting so bad here. Maybe we're coming to the end of the jokes. Oh, bite your tongue. Bite your tongue. Maybe I should, I probably should go to like the cleaner ones. Ed, how are you? What did we do yesterday, Ed? We did our first big branded advertisement deal, which was fun.

Less awkward than I thought it would be. Scott and I talking about some software product. I'm not sure if we're supposed to talk about what the product actually is. But yeah, you and I,

You and I sold some ads yesterday. Yeah, it was kind of strange. So first off, just some tips. When I was your age, I was uncomfortable with that sort of stuff because let's be honest, you're a total whore and you feel like you should shower afterwards. And so basically it was a giant tech company and they had this enormous, it looked like a taco truck, but it's actually to demonstrate the product. There's probably 40 people there. And I could tell that you're not used to that. When you get to my age, you're literally willing to like whore out your ass. I mean, you're just like...

Oh, there's money involved? Sure.

And I could tell you're sort of like, this doesn't feel right. Yeah. But it felt better than I thought it would be. I mean, I really thought I'd feel extremely awkward talking about how great these products are. But I ended up, I think they did a great job. It's a good product. It's a good product, exactly. So I didn't have to lie. And they did a good job of making it feel somewhat normal and natural. So I was actually pleasantly surprised by how not awkward the experience was. Still awkward.

but way less awkward than I would have expected. Yeah. It reminds me of the time I was in Paris and I was staring at the Eiffel Tower with my partner. And I'm like, this is the third time we've been here and they still haven't found oil. Get it? As if it's an oil... Oh my God, Ed. Ed, seriously. It's hard to follow these jokes when they have nothing to do with the preceding conversation. Yeah. If there was some slight link, I might've gotten it.

but it sort of just came out of nowhere. All right, get to the headlines. I'm done. Get to the headlines. Before I do that, I want to remind our listeners we have a weekly newsletter on

Prof G Markets. It breaks down the key market moves with data-driven analysis and crisp visuals every Monday. So a reminder, please go subscribe now at profgmarkets.com. We'll also leave a link in the description of this episode to make it easy for you to sign up. If you don't have time to listen to the podcast, this is a good way to sort of get your quick hit in your inbox in the morning. So please go subscribe to that. And with that, let's get to the headlines.

Pharmaceutical stocks dropped after Trump said he had a plan that would significantly slash drug prices in the U.S.,

However, the stocks quickly rebounded after he signed an executive order that lacked any legal mandate for companies to bring down prices. Instead, the order asked them to lower prices voluntarily. AI startup Perplexity is in talks for a $500 million funding round that would value the company at $14 billion. That's more than 50% higher than its last valuation from just five months ago. And

And finally, Coinbase shares rose more than 20% on news that the company will join the S&P 500. It will be the first digital asset company to be included in the index. So Scott, let's start with what happened with pharmaceutical stocks. First, they dropped after Trump said that we're going to have this big price decrease plan on drugs in the US. Then he signed the executive order and the stocks rebounded again. Your reactions?

The market is essentially saying what every foreign leader is saying, and that is with respect to the president, you are not serious people. A most favored nation status where he claimed that all our drugs would have the lowest price or match the lowest price.

of any price around the world would have absolutely not decimated, but substantially hit the profits of pharmaceutical firms who have been able to weaponize. They've recognized the ultimate business model in America in terms of return on investment isn't investing in people. It isn't investing in AI. It's investing in our whores that we call elected representatives.

Because the disappointing thing about our elected representatives is not that they're whores, it's that they're such cheap whores.

And when Cigna or Aetna or Pfizer give a few million dollars to different people, they can figure out laws that make it such that we have to pay eight times for Ozempic and Humira what other nations pay for these pharmaceuticals, despite the fact that we invent, manufacture, and distribute the majority of these drugs. We're number one in terms of IP for pharmaceutical development.

But we have figured out a way, or these companies have figured out a way, given Citizens United and the fact that you can buy elected representatives, you can buy lawmakers, a way to charge American consumers more. And then you have an infrastructure where essentially the bill is opaque and usually your company is paying for it. So what do we have? We have opaque pricing that has no consumer scrutiny.

We have regulatory capture and we have profit-seeking companies which are doing what they're supposed to do. So we end up with $13,000 per capita health care versus $6,500. And in exchange for that, we're more obese and we die sooner. So these companies had...

come under any sort of reasonable threat that they might actually have to give Medicare or Medicaid the ability to negotiate these prices would have taken an enormous hit. And that's what happened right after the release. The data hadn't been absorbed and the stocks were down two to three percent. And then people read it and said, oh, this is the president presidenting doing jazz hands, saying fucking nothing, trying to get in the news, trying to pretend he's doing something.

with absolutely no strategy. This thing has absolutely no teeth. If you read the executive order, it's that he's suggesting they do it. He's saying this would be a good idea. And what do you know? Stock prices ended up, pharmaceutical prices ended up higher because what this said to the market was Congress has the limpest dick in the world right now with their ability to go after healthcare costs. That even if the president makes a proclamation like this, there's no fucking way

That this is actually going to happen. This is, as you can tell, a little bit triggered. If you look at our deficit, which we have to get under control, otherwise you are just not going to have nearly the prosperity or opportunities my generation registered. The only way we're going to get to that $2 trillion a year is the following. Full stop.

G7 nations pay on average $6,500 per capita for healthcare. We pay 13,000. 350 million people times the $6,500 incremental, that's about $2.5 trillion. In sum, just the incremental cost to be more anxious, obese, and die sooner is costing us an incremental $2.5 trillion because of regulatory capture. And this stock market movement reflects the fact that

that we have the most onerous, usurious, damaging regulatory capture in history that creates ridiculous, opaque, and insidious massive healthcare costs and a drag on the American economy. And this was the market saying, yeah, nice try, boss. Your thoughts? Are you saying we need to cut spending on Medicare and Medicaid? What

What is your suggestion there in terms of how this all relates, how deficits relate to health care? I mean, if you wanted to lift up the economy and flush an additional $2.5 trillion into other things, all you need to do is bring our health care costs in line with

with other G6 nations who are healthier. So this would have accretive benefits across the entire economy, including lower costs on social services, lower burden on government services, more profits to tax,

This is all roads lead to the same place. Should we tax billionaires more? Yes. Do we need to cut Social Security? Scott Galloway should never get Social Security 100%. We should raise the age. You're going to probably live to be like 190. So the notion that you should start getting Social Security at 65 makes no sense at all. There are a lot of things we can do. Nothing gets us there.

Unless we go after this. Just as an example of how crazy the prices are, there's this diabetes medication I was looking at called Jardiance. One month supply costs $611 in America. In Japan, it costs $35. It's not as if everyone in Japan is poor in the prices. I mean, that's just an unbelievable price.

And again, the markets are telling us the true story here. I mean, Trump comes out and he says over the weekend that he wants to pursue this most favored nation policy, which basically means that drugs must be priced at their cheapest levels for the U.S. If that drug costs $35 in Japan, it should cost $35 in America. And it's such a shame because I was actually very excited to see that.

I mean, he's going after the right issues, which is we need to do something to lower the cost of drugs and the price of drugs in America and pharmaceuticals. And the fact that the market was reacting and getting worried about it, and these pharma stocks were hurting as a result of those comments, to me was a great sign. But then, of course...

the whole thing came undone when suddenly he signs the executive order and you learn, actually, there's nothing to do with this most favored nation policy. All he's doing is saying, hey guys, please reduce the cost of drugs. And then all the pharma stocks rip back up because basically Wall Street's reaction is, great, that means prices are not going to come down. If you simply ask

a company to reduce their prices, they won't reduce their prices. This is market dynamics. They're only going to do it if they have to. And the only way you can do that is by pursuing a legitimate legal framework that forces them to bring down their prices. And that's not what's happening. So it was a shame for me because I was about to be very

supportive of Trump and this move and what he's addressing. And I was thinking it would be one of the first things where I'm like, yeah, he's got this right. But once again, he just shows that he lacks the competence to actually follow through with these things. And so it's going to continue business as usual. You got to give the guy his due. He does have sometimes the right instincts, like let's ban TikTok. Oh, wait, TikTok's good for me. And I have a political donor. Oh, never mind. Now I like it.

Sometimes he has the right instincts. He has absolutely no ability to execute and thinks he's a deal guy. But to give you a sense of how outrageous this is, on average, we charge about four times the price for pharmaceuticals of what other nations pay. That's the equivalent. So Saudi Arabia, the kingdom,

They produce a lot of oil. I don't know if you heard this. They produce a lot of oil, Ed. Now, why is it less expensive in the kingdom? Because we make a lot of this shit. So let's take advantage of the good work our domestic citizens do, providing the exceptional or pulling out of the ground this exceptional blessing, this sitting on this sea of oil. So we'll give them less expensive gasoline. We produce more oil, i.e. pharmaceuticals, than any firm in the world.

Do we, in fact, charge less for it? No. It would be similar to if Saudi Arabia decided they were going to charge $10 a gallon. We produce it, but I know Saudi Aramco figures out a way to weaponize the kingdom and the leadership and convince them that they should charge $10 a gallon despite being the biggest producer of oil.

I've gotten off track here, Ed. Let's go to the next story. Let's talk about perplexity, which is raising a round that would value the company at $14 billion. That's up from its $9 billion valuation from just a few months ago.

Reminder, this is the AI company competing with OpenAI. The deal isn't finalized, but I think we can assume it's as good as finalized. I mean, these leaked journal reports are usually pretty spot on. So assuming it is, that would make Perplexity the fourth most valuable AI startup in

Ahead of Perplexity, we've got OpenAI at $300 billion. We've got XAI at $80 billion, though, as I've discussed, that number is kind of bullshit, but whatever, we'll ignore that. And we've got Anthropic at $62 billion. Perplexity is number four. Scott, any reactions to this new round, this new financing round from Perplexity? I've always thought Perplexity's core asset is it's got a really clean positioning.

It's the search AI or it's the AI search, right? I think this is example of kind of the froth here. Their annual recurring revenue has grown from 5 million in January 2024 to 120 million. So obviously it's going like crazy. They've got they registered 160 million visits compared to open as 5 billion. So what is that about 30 times more and Google's 85 billion visits.

So as a multiple of revenues, it's getting about 140 times ARR, whereas OpenAI trades at 25. So I think this is – I think if OpenAI gets public, which I believe they will, I think this is a tuck in acquisition. And they rebrand it as the more pure place search component of OpenAI or of Anthropic. I don't think this is –

Let me ask you, because you and the team understand AI and the consumer-facing applications better than I do.

What's to stop OpenAI from launching a perplexity killer? I would argue that they already have. I mean, my gut reaction seeing just the $14 billion number was that it actually seemed quite small. I mean, $14 billion for this AI company we keep hearing about, and then I compare that to OpenAI at $300 billion. So OpenAI is 2,000% more valuable than perplexity. My sort of gut reaction was, oh, I wonder if that's

And I think the question is, you know, is the valuation accurate? Is the valuation fair when you compare it to just how gigantic OpenAI is? My sense is, yes, it is fair. When you look at the numbers, it's very obvious just how far ahead OpenAI is compared to Perplexity. I mean, Perplexity, they're getting 350 million monthly visits. ChachiBT is getting 14 billion. You look at the monthly unique visitors per...

Perplexity is getting 17 million. ChatGPT is getting 374 million. You look at the amount of time that people spend on these sites. For perplexity, it's about six minutes. For ChatGPT, it's seven. So I think on the surface, it might look

possibly undervalued just when you compare it to OpenAI. But I think it's a reminder again to look at the underlying numbers, which would tell you that yeah, OpenAI is miles and miles ahead of Perplexity. If you were to read the headlines, you'd get the sense that it's a little bit of a race.

that it's open AI versus anthropic versus perplexity. But I think what's happening is open AI, as I've said for a long time, I believe they have for years been running away with it. I don't see any real indication that perplexity can catch up. I appreciate your comment that they were early to say this is AI for search.

But I think the whole AI game has developed so much since then to the point where everyone now recognizes ChatGPT is taking on Google. If I had to invest in one AI startup, it's no question for me, even at $300 billion, it would be OpenAI. So the question is, what is the point of differentiation? And the point of differentiation has to do with perishability or kind of real-time versus...

legacy, and that is if you think about ChatGPT, it's a generalist platform for content creation, writing code, producing visuals, whereas perplexity

as real-time web search. ChatGPT has that now. I mean, ChatGPT started out with, and it was a big problem, like you couldn't get up-to-date news, but they've solved that now. Because it's funny you say that, because my brand perception is when I say, can please distill and give me a sense for if there are winners and losers in the proposed UK trade agreement, I think of perplexity, because I assume it's going to have more up-to-date information, and you're saying that's not accurate.

By the way, I don't use Perplexity myself, so I think we just have a difference of use case. But if you're using ChatGPT today, I will tell you personally, I use it in the same way I'd use Search. This is a capital race. They're going to win. Let's move on to Coinbase. Last year, it was fighting these investigations by the SEC. This year...

Suddenly, the SEC drops all those investigations under the Trump administration. Now it is in the S&P 500. As of this week, it is replacing Discover Financial. Scott, your reactions to this news? Look, I was a hater, and I like to think I've evolved as a human and I'm open to learning. I think Coinbase, consumers have decided this is for them a legitimate asset class. And

They get to decide that. I do think the lack of regulation here is somewhat frightening that on April the 9th, just a few weeks after Trump launched his Trump coin, they decided to shut down the unit of the Department of Justice investigating crypto fraud. So it's a bit of the Wild West. To be in the S&P 500, the S&P 500 has a committee that selects companies based on a blend of quantitative and qualitative judgment.

And you're supposed to have at least a market cap of $21 billion, a lot of liquidity, a public float of greater than 50% shares available to the public. You're supposed to be profitable. And I do think that the S&P, it's a really interesting construct, the synthetic grouping, if you will, because it essentially says we're going to do a lot of diligence on what are the best American companies.

And then index funds can come into it. And there's something sort of simple and magical, and that is they kick out a company like Discover and say, you're no longer one of the best 500 companies. Which got acquired. So that's why they're doing this reshuffling. But yes. They got acquired by Capital One. Is that right? Yeah. Yeah. So it's sort of when you invest in an S&P index fund, you're not only getting diversification, but what you're getting is

So you're benefiting from this committee's attempt to be the arbiter of what, in fact, are the best companies. So when you buy an S&P company, the natural assumption is you are getting companies that are not only great companies, but quite frankly, they're still either maintaining their greatness or on the upswing. And then they kick out companies, which I really like. Yeah.

So this is a big deal. This is a, you know, when you're especially this kind of legitimate, to a certain extent, this fairly unfairly legitimizes, in my view, the asset class. Or when was it they announced ETFs or JP Morgan or some? BlackRock last year. So this is yet another kind of signal of them legitimizing it. Now, at the same time, this could create.

Be inflating the bubble even more. I mean, if this shit does fall and become the ultimate Ponzi scheme where there's no underlying cash flows to justify any of this shit or no real asset, it just means more retail investors are going to get hurt because the assumption is that if it's an S&P company, there must be some credibility to what they're doing.

So I'm sort of, I'm lukewarm on this. I don't know how to feel about this. Ed, your thoughts? I'm pretty staunchly cold on this. I think this is really bad. I love that the young guy hates crypto. Who would have thought that? Who would have thought that? Look, I think it's one thing that we have a market that is predicated on assets that have no underlying or fundamental value.

And for the sake of this argument, let's just like, let's ignore Bitcoin. And let's just focus on all the other stuff, the $1.2 trillion worth of non-Bitcoin crypto assets that

that are floating around out there that are being traded on Coinbase. So Ethereum, Tether, Ripple, but also the meme coins, Dogecoin, which is the eighth largest cryptocurrency by market cap, one of the most traded coins on that platform. Trumpcoin, Pepecoin, Comrocketcoin, which I know you love, Fartcoin. All of these things exist on Coinbase. And the way Coinbase makes money is it takes a little fee when you trade this crap.

So look, it's one thing to have a marketplace for these assets. And I don't have a real problem with that. I think it's dumb, but I don't think it's wrong. I don't think it's morally wrong. It's an entirely different thing, in my view, to push that marketplace and those assets into the retirement accounts of practically every investor in America. I mean, no one doesn't own the S&P 500. Everyone owns the S&P 500, which means...

Everyone owns Coinbase. Not a lot, but a little bit. It's going to be around 0.1% to 0.2% allocation, which is going to translate to around $10 billion in net purchases by these index funds. Now, the reason I think this is such a problem is

It's really reminiscent to me of the 2008 financial crisis, because if you look back at what happened there, the problem wasn't just mortgage-backed securities and these mortgage-backed security derivatives and these CDOs.

Those were actually like in real terms, it was a very small slice of the economy. The problem there in 2008 was the institutional adoption of those bullshit assets. It was the fact that the banks were embracing them and aggressively marketing these CDOs. And that's what led to the investment world building this giant infrastructure around these shitty assets and

And that's what caused all the pain in the end. It wasn't the assets themselves. It was the fact that we built all of this up and we got all these retail investors and these regular people tied to these assets. So I look at what's happening here. I look at MicroStrategy entering the NASDAQ, now Coinbase entering the S&P 500. I really see no difference.

I mean, these are like highly financialized, highly derivative assets that offer no real value in the real world. Again, we're just going to exclude Bitcoin for the sake of the argument. Still $1.2 trillion in assets there.

And now you have these institutions embracing them, which means that the rest of America is coming along for the ride now. So if you own the S&P 500, you now own Coinbase. And that's very similar to 2008. I'm not saying we're going to see this 2008 crash, but the dynamics that are at play here are basically the same. So...

You know, as you know, as everyone knows, I have my issues with crypto. I've talked about why I don't like it personally. But thus far, it's not been a huge problem for me because thus far it's been opt-in. Like if you don't want to own this stuff, you don't have to. Just don't get involved. But that's no longer true now. Like I don't like crypto. I don't want to own Coinbase, but I now own it.

And to me, that's a massive failure of leadership on the part of the S&P 500, who I believe should hold different levels of standards for that portfolio. I think they have a unique level of responsibility in the investment world. This has to be grounded. This portfolio has to be grounded in fundamentals. It has to be grounded in value. And you can't just sling these very precarious assets into people's retirement accounts. So...

Like, I was against crypto before. I didn't think it was that systemic of an issue. Now that this has happened, combined with microstrategy in the NASDAQ, I believe this is systemic. To me, it's now turning into an actual problem. I think you're the problem of the Democratic Party right now, and that is you're more interested in acquiring social status or a political orthodoxy than increasing the material or emotional well-being of Americans. Do you think that—are you still worried about every American owning fossil fuels? No.

That's a real business that has real value in the real world. Are you cool with tobacco companies being in the S&P? People like to smoke. That's real. That's actual value in the economy. Actual value. So your issue here is that there's no underlying...

cash flows or your belief is it's not an income producing asset. Yeah. My issue is that we are now attaching the value of people's retirement accounts to a company that makes money on trading Comrocket and Fortcoin. That's a good point. I literally respect the fact that

When you go to parties, you're like the guy, you're like the 26-year-old that doesn't like crypto. Literally that. The guy who sucks. It's like, no one knows what to make of you. You're like, you might as well start singing show tunes and sing. Does none of what I say resonate with you? Or do you think I'm being pedantic? Or what do you think? I like what you're saying because I find that I'm a little bit taken in by, you know what it is? I think that people my age,

And because I desperately want to reach young men and I'm going through a midlife crisis, so I want to feel younger than I am.

that I try to be a little bit hipper and younger. And I mean, look at me, I'm dressed like an aging skateboarder right now. I look fucking ridiculous. But I think a lot of people want to be seen as younger and hipper. And so they embrace crypto because it makes them feel young. Yeah, for me, it's like a combination of that and Beanie Babies. Like, we're just...

buying and selling Beanie Babies and driving up the price. And again, I don't want to outlaw Beanie Babies, but I don't think Beanie Babies and platforms whose main way of making money is by taking fees off of Beanie Babies being traded, I don't think that should be in people's 401ks. Let me put it this way. If this shit ends really badly, I think a lot of us are going to have our head in our hands and go, well, of course it did.

Of course it did. Which, again, feels so 2008 to me. And most importantly, this whole conversation has inspired my favorite line from a song in the aughts, and that is, I'm so 2008, you're so 2000 late. I love that line. What is that, Black Eyed Peas? I don't know. That's Boom Boom Pow. If it's not Tom Petty or Tom Petty, I don't care what it is. Ha ha ha ha.

We'll be right back after the break for our conversation with Alice Hahn. If you're enjoying the show so far, be sure to give the Profit Market feed a follow wherever you get your podcasts.

And according to ZBiotics, here's how it works. When you drink, alcohol gets converted into a toxic byproduct in the gut. It's this byproduct, not dehydration, that's to blame for your rough next day. Pre-alcohol produces an enzyme to break this byproduct down. Just remember to make pre-alcohol your first drink of the night. Drink responsibly and you'll feel your best tomorrow. This is the part of the ad where I'm supposed to talk about my personal experience. I have used

Z Biotics and I have found that the next morning I feel less bad. I'm also trying to cut down my alcohol consumption because obviously that's the best thing to do to feel less bad the next morning, but I'm also using Z Biotics. Go to zbiotics.com slash Prof G to learn more and get 15% off your first order when you use Prof G at checkout. Z Biotics is backed with 100% money guarantee. So if you're unsatisfied for any reason, they'll refund your money. No questions asked.

Remember to head to zbiotics.com slash PropG and use the code PropG at checkout for 15% off.

This episode is brought to you by Amazon Business. How can you free up your team from time-consuming office tasks? Amazon Business empowers leaders to not only streamline purchasing, but better support their teams so they can focus on strategy and growth, free up your teams, and focus on your future. Learn more about the technology, insights, and support available at amazonbusiness.com.

Close your eyes, exhale, feel your body relax and let go of whatever you're carrying today.

Welcome back. Here's our conversation with Alice Han, China economist and director at Greenmantle.

Alice, where does this podcast find you? I'm in London, but the weather is getting warmer, which is nice. I'm going to head to Ibiza and a couple of warm places for conferences, which is good. That's fun. Yeah, I've heard. Unfortunately, I leave just in time for the nine days of nice weather in London. I know. So let's bust right into it. I'm just curious to give us sort of the state of play in China on the ground, the citizens, businesses, and government officials and their response to

to the trade war and tariffs? And what is the general vibe, if you will, in their response and perception of what is going on? Well, it's a great question, Scott. And I was actually in China a month ago at a track two dialogue between Australia and China. So I had the chance to meet with government officials and talk to people on the ground. Barring, obviously, what has happened in the last 24 hours, I would say that when I was there in the midst of the huge tariff hikes, 50 and then 100 percent on top of the 30

percent or more after Liberation Day. What the vibe was on the ground was that China will defend its position at all costs. There was a revival of Cold War II Korean War rhetoric about being able to defend against U.S. hegemony. But more importantly than that, there was a confidence that they had the fiscal monetary capacity to offset some of the shock. Now, with tariffs risking at the height of 145 percent, this was going to be a very daunting task. But I was struck by the fact that

that A, the policymakers had spent the last eight years not only aggressively rerouting trade through third-party countries, but finding ways to cushion the blow, as they saw in Trade War One. And secondly, there was this feeling on the ground that there was going to be more policy support, especially for the private sector, for the tech sector,

I saw tech executives being more positive and ebullient about the future pathways more so than in any time since 2018. So that was the feeling on the ground. Obviously, I would say in the last 24 hours, we're seeing remarkable improvement and sentiment, I would say, because we now have a complete diminishing of the risk that was being held for Chinese companies and as well as the Chinese macro situation, which was these exorbitant tariffs.

So I would say I was struck by how confident China felt. And comparatively speaking, when I'm in the U.S., I would speak to my American counterparts. The reaction is very dismal on the ground. So it's been a tale of two very different stories. Well, it's just to that point. Didn't Trump blink? I mean, at the end of the day, didn't she basically say, bitch, I'm on top, for lack of a better term, and say,

And when? I completely agree with you, Scott. Even though I always like to be contrarian, especially in conversations with intelligent people like you and Ed.

I would say that China has become James Dean in that film, Rebel Without a Cause. It won the game of chicken because it had escalation dominance and it had more political appetite to increase the tariffs. And Trump clearly didn't. He had to listen to the Bill Ackmans, the billionaires of the world, who were reminding Trump not only was this going to hurt his base, but shelves would be completely empty. And I think that he caught on to that and he was very much convinced by that.

So the Chinese, I think, feel very vindicated in their strategy, which was to do tit for tat tariffs like for like. And in the last 24 hours, that position has been successful for China. We've seen Trump obviously blink on these tariffs. And I could foresee even more negotiations downward if these fentanyl talks move swimmingly, which Besset, for instance, thinks they will.

Alex, the reductions that we're seeing on these tariffs, 145% to 30%, there's the US tariffs on China, China bringing theirs down from 125% to 10%, those are supposed to last only 90 days while talks continue. And the thing that I can't really figure out is like, what are we even talking about with China?

Like, what deal is supposed to be made? What are we trying to get from China? And what is China trying to get from us? Can you give us some color on what these talks are even about and what the goal of these talks would be?

Trump ultimately wants a big beautiful deal. He was pen pals with Nixon back in the 80s. He admires the fact that Nixon went to China and made this big beautiful deal. So he ultimately wants to see a deal. The people around him, I would say Jameson Greer for instance, really cares about trade imbalances and macro reciprocity. He will want to reduce the deficit. He will want to increase segmental or sectoral specific tariffs on certain Chinese products, especially in dual use.

or very tech competitive industries. I could see that happening up to 100% or more in some of these sectors. And similarly, he will want market reciprocity. Besant is in the same camp, I would say. He would want to see China reducing its restrictions on foreign, especially American investments going into China, allowing more equal participation for US investors in China.

And similarly, China buying more American products. So it's not a surprise that Besant said we had a great deal in phase one. I think that they will go back to aspects of that, ask China to increase agro-purchases and purchases of energy products more.

and similarly find ways for China to reduce the subsidies on certain goods which they believe to be unfair trade practice. Elsewhere, I think that Trump really cares about fentanyl. He will want to see some kind of cooperation on China reducing the subsidies for the precursors to fentanyl. I'm a bit more optimistic now that there could be some kind of cooperation that would enable that discussion to happen. And on the Chinese side... Could you break down, sorry, I just want to

because the fentanyl thing is so confusing. Could you explain to us, like, what is the actual connection between China and fentanyl? Like, in what sense is China propping that up? So China subsidizes industries that produces the precursor chemicals for fentanyl, effectively

creating these cheap fentanyl products that then get flooded into the American market. Now, China says it's cracked down on fentanyl itself exports to the U.S., but the precursor chemicals are still being produced by China. So I could foresee more collaboration on that front for China to again reduce or even cut off all exports of those chemical components. And that would be seen as a win for Trump and for his political base.

On China's side, all that they care about is that they want to achieve a degree of supply chain self-sufficiency, especially when it comes to the harder areas like semiconductors. They want to keep growing and not have these huge trade risks that Trump poses.

And they want to extract geopolitical concessions potentially in the long term over Taiwan. That is a long-term game, but I think the two first priorities are how do we grow stably and how do we maintain supply chain dominance and resilience.

Does rebalancing the trade deficit really get in the way of those goals for China? Like, I'm just trying to think about what a big, beautiful deal looks like for America. And it sounds like we sort of rebalance the deficit in terms of trade. China just buys more of our stuff. They also get their act together on fentanyl, whatever that would look like.

In what sense does that get in the way of China's goals? I actually don't think it gets in the way of China's goals because I think it is in China's interest to rebalance. They've said this for over two decades now, but when push comes to shove, they've been faced with some kind of slowdown or economic crisis, be it GFC, be it COVID, be it trade war one, and they've walked back.

on some of these rebalancing efforts. So I think it's in China's interests and policymakers are realizing this. When I was in China a month ago, they were starting to say that overcapacity was an issue and that they need to do more to rebalance. I had never heard them say that before. In previous days, they were saying this was free market competition and the West should be so happy to have cheap Chinese renewable technologies, green technologies. The fact that they're saying that seems to me to suggest that they need to rebalance, they realize that.

And that actually this is an opportunity for China potentially to buy more American products, to address some of that trade imbalance that the U.S. is rightly, I think, complaining about. And find ways to maybe even invest in the U.S., if Trump and the Republicans allow it, to create manufacturing jobs in the U.S. because China has the logistical, the manufacturing know-how. So I think that the China-America relationship has...

the ability to have a second chapter in its relationship and not go through a full-scale divorce or decoupling. But again, it all comes down to politics, Ed. And that is where I'm not so sure. Yeah, I was going to say, I mean, the way you lay it out, it sounds like a kiss and make-up between the US and China is actually very easy. I mean, based on everything you've just described there, our goals are not really at odds with each other. So I guess my main dumb question is...

What's getting in the way? Like, what's the problem? Why can't we just figure this out? The problem on the Chinese side is that they cannot countenance a massive slowdown in the economy. So instead of going through the, I would say, the American model, for instance, sort of 1930s depression, or even World War II, where you saw a massive crisis that then enabled the consumer share of GDP to continue to rise,

rather than the manufacturing share of GDP, which is why America is now a consumer and services-led economy. The Chinese are unwilling to countenance that. They don't even want to have a Japanese style, you know, lost decades, which is a slow version of what we saw in the America.

So instead, they want to walk on this tightrope between rebalancing a little bit here and there through subsidies for consumer goods, like the trade-in appliances. And at the same time, they will increase Chinese exports, increase potentially infrastructure spending on certain infrastructure. And this means that they have this impossible task of balancing the two because ultimately they don't want to go full on

and the rebalancing mode, which is something that they recognize that they need to do. That is a structural bug in the system, and it's going to be very hard to shake for political reasons. On the U.S. side, why they can't kiss and make up is because we have different parties with different interests. As we mentioned, Trump wants a big, beautiful deal. As I've said before, he's the biggest dove in a house full of hawks. Besson wants to make sure that people around him and Wall Street are happy, that the markets are happy.

And Jameson Greer wants to have a more level playing field. People like Navarro and Lutnick are a bit more crazier, I think, and don't really know what they want to do, which is why we saw the April 2nd tariffs. So we have really heterogeneous outcomes coming out of the U.S., which, again, is deeply, deeply confusing, not just for us, but for the Chinese as well. My sense is, I mean, it's pretty clear what my bias is. I'm not an enormous fan of the current U.S. president.

But when I have – I've spoken to some – I have some data here. I've spoken to – or anecdotal evidence. I've spoken to some European companies who are contemplating working with not only Chinese companies but divisions of these Chinese companies including their cloud units and working with their – these units that they would have never considered before. So distinctive what – how this trade war calms down.

Isn't this just an enormous opportunity and gift for Chinese companies who are now getting meetings they otherwise wouldn't have had the opportunity to get in Europe and Latin America? I mean, I completely agree. I think Latin America was always going to be under Lula in China's camp. It's not a surprise at all.

that Lula's now in Beijing signing a trillion dollars of deals in Chinese investment in Brazil and purchases of Brazilian agricultural products as China again tries to diversify away from the US towards Latin America. But I think the real winner is going to be the ability to launch a successful trauma offensive with Europe. I think Europe was very sickened by Trump's treatment of Zelensky in the Oval Office and his behavior towards Europe, not just Trump but Vance, their behavior towards Europe since then.

And I think Europe, as is its historical want, is going back to strategic autonomy. It's trying to hedge between these two superpowers, China and the U.S. And I think in this current climate, it is probably veering more towards China on trade because it sees China as the adult in the room. And I think what's going to be interesting, Scott, at the end of June is two really important meetings. We're going to have NATO.

at the end of June, and then the China-EU summit at the end of June, now in Beijing, not in Brussels, because they ultimately wanted to show respect to Xi Jinping, who originally couldn't make it. So I think this is going to be a real stress test for transatlantic relations, and it could mean that we see further reduction in trade and non-tariff barriers between the EU and China come end of June, which is something that Trump won't be very happy about. He's already saying that the EU could be nastier than China, so I think that the EU is next in the firing line, so to speak.

And just moving to the broader Chinese economy, there were reports that felt legitimate that China, this came, the threat of a trade war came at a terrible time for China. That China has some real structural economic issues. Distinct to the tariff war, talk about the state of the Chinese economy right now. I would say, Scott, the state of the economy is a story of two really divergent Chinese economies.

Number one is what I would call a structural macro slowdown. And that is driven, as you mentioned, Scott, by these challenges, the real estate sector being one of them, but also the fact that private consumption remains remarkably weak, only 40% of GDP compared to 70% or more in the US. And it's structurally going to be very challenging for the government to try to rapidly rebalance and increase the consumption share of GDP, which I'll get to in just a bit.

But its over-reliance on exports, I think, will remain a theme moving forward. It needs to have that export engine, the overcapacity engine, to maintain growth. As long as it has these GDP targets, it will need to have a degree of overcapacity. And I think in this environment of weak and low interest rates, which are favoring the exporters, this is going to continue the financial repression story that we've seen for households for decades.

What I would say, though, and sort of counterbalancing towards this is what I would say is a bullish tech story or bullish tech side to China's growth. And I think that this is going to potentially increase some of the rebalancing towards consumption. The reason I say that is because

Not only are we seeing more services, some of this geared towards AI and the usage of AI in healthcare, in elderly care, in retail and manufacturing, but we're seeing these tech companies come up with really inventive ways to create new markets. I'm optimistic that Chinese tech will be very, very resilient and it will find more ways to be even more self-sufficient and have supply chain resilience.

but it could create more products and services that, again, could boost consumption, reduce the cost of certain services and goods. So I'm bullish on some parts of the tech story and bullish on some parts of the consumption boosting story, but I see these structural challenges still in play, and that means a net increase

disinflationary environment for the rest of the world because China needs to produce more. And if the U.S. is not going to buy it, then it's going to have to export to other economies, maybe the European market, for instance. So it's two very different pathways for China. But I come out from this trade war feeling that the Chinese policymakers have more resolve

to again expedite some of these structural trends towards consumption. And in case of backlash against overcapacity, to reroute through these third parties. We saw 20% year-on-year increases to exports to ASEAN. I think that this will continue to gear up as they try to avoid any future tariffs from the Americans. Stay with us. Put us in a box.

go ahead. That just gives us something to break out of. Because the next generation 2025 GMC Terrain Elevation is raising the standard of what comes standard. As far as expectations go, why meet them when you can shatter them? What we choose to challenge, we challenge completely. We are professional grade. Visit GMC.com to learn more.

Summer's here and Nordstrom has everything you need for your best dress season ever. From beach days and weddings to weekend getaways and your everyday wardrobe. Discover stylish options under $100 from tons of your favorite brands like Mango, Skims, Princess Polly and Madewell. It's easy too with free shipping and free returns. In-store order pickup and more. Shop today in stores online at nordstrom.com or download the Nordstrom app.

As a contractor, I don't pay for materials I don't use. So why would I pay for stuff I don't need in my mobile plan? That's why the new MyBiz plan from Verizon Business is so perfect. Now I can choose exactly what I want, and I only pay for what I need.

We're back with Profiteer Markets. My sense is that China, even before this tariff or trade war, was divesting away from the U.S. I believe the percentage of their exports had fallen from 24% to 17%.

Is that a concerted strategy that we just, they're not good partners and we need to divest away from the United States? Is that, is it, which I think is a terrible thing. I think the less inextricably linked we are, the more likely we are to declare war on each other or take bigger risks with each other. But could we see that 17% number drop to single digits in the next few years?

So, Scott, I love this question because I think we always need to look beyond the data. So back in 2018, we saw the U.S. share of Chinese exports being 20 percent. It's now around 14 percent, if not under. That is not the full story because the Chinese surplus, trade surplus to the U.S. has increased quite a bit since 2018.

So what we've actually seen is that China is rerouting its trade through other parties in Latin America and Southeast Asia to, again, they call it tariff washing, to avoid some of these tariffs or restrictions that the Americans have put into place.

So that number, I think, again, is a bit of a misleading number. And again, we shouldn't forget that if we just look at the trade imbalances, China is a bigger trade surplus-running country with the rest of the world and the U.S. than it was in 2018. Again, it's a sign that it doubled down on this export engine because, as you mentioned, Scott, consumption wasn't doing well, local governments were debt-ridden and needed to pay their debt burdens, and the real estate sector was suffering. So I think

Chimerica has become even bigger. The divorce settlement has become even bigger. But what Trump has shown today, or rather yesterday, is that it can't afford this divorce settlement because China keeps increasing the stakes.

Coming out of this war, we tend to talk about who loses or gains more. And I think a lot of people are coming to the conclusion that over the medium and the long term, China is probably going to get the better of the deal. But distinctive what's good or bad for the U.S. or China with respect to this tariff war, who do you think are the other big winners and losers? It feels like Europe will be a big winner because it seems like the Chinese are excited or ambitious to establish better relations with them. But are there other nations in Southeast Asia that vis-a-vis this trade washing, or I think that's the term used, are going to be better?

are just sort of unnatural winners here, are going to do really well, like trade off of, you know, selling bullets to the warring parties, so to speak? Yeah, that's a great question. I think in Southeast Asia, it has to be India because Apple and other companies are going to continue to diversify the supply chains and find alternatives for their components outside of China. And this is already happening. I think this wraps up

quite exponentially the plans to, again, move some of the factory processes to India. I think Vietnam and Indonesia and Malaysia, again, when it comes to final assembly or even manufacturing, will be beneficiaries. We've already seen massive greenfield investments from Chinese companies. I think that that continues in those countries in particular. So we should see a ramp up of their manufacturing output going to developed economies, including the U.S.,

And in Latin America, I think Brazil is going to be a huge beneficiary. It's not a surprise that Lula is in Beijing signing that deal. We've seen in the last few years, Brazil overtake the U.S. in terms of being the biggest exporter of wheat, soy and corn to China, which is their biggest market.

So I think some of the Latin American agro producers are going to be beneficiaries of this as China again tries to diversify away from the U.S. And similarly, I think that Europe could extract certain concessions. This is why I'm bullish at the end of June that there could be some kind of a deal over EVs or even Chinese investment in Europe.

There's been discussion about potentially launching price minimums to get rid of these tariffs, this 40% and onwards tariffs on Chinese EVs that the Europeans have imposed. And similarly, I could see the Chinese being more lenient on some of these tech transfer details for Chinese companies to effectively enable IP transfer to their European counterparts and partners when they establish factories in Europe, especially relevant for batteries and other EV components.

So I'm bullish that there are some beneficiaries in all these different regions. But again, I think that America had its chance, Trump under Trump, to really squeeze China when it comes to trade and even some of these tech sanctions. But again, because Trump blinked, I think he rendered that null and void. So Alice is the Chinese analyst for Green Mantle and advises people at the highest level around their investments and their strategies.

I've been actively looking at European and Chinese stocks, and I'm absolutely fascinated with BYD. I just can't, you know, I see these TikToks of every single, you know, I see the performance of a car that seems to be superior to cars that cost four times more. I'm curious what you think of BYD, what it says about Chinese manufacturing, if it has the same. Talk about the BYD phenomena. What do people locally think of the brand?

And what does it say about the state of kind of Chinese manufacturing right now? And I'm fascinated with this company. I would love to get any color you might have on it. Well, Scott, you should, you know, I've got people in the region, so you should definitely go and visit. We can get you into an EV if you want in China very soon and give it a test drive. But on the ground, I mean, it's one of the huge success stories. And I think that they've pressed play on autonomous driving, which is potentially going to give them even more upside.

when they begin to roll that out in China and then globally. And beyond that, I was reading an interesting diagram of the way in which BYD is involved in so many different industries. And this is a way in which I think Chinese manufacturing can be seen as more competitive and advantageous, is the fact that you've got companies like Huawei and BYD that don't just produce cars or smartphones. They're involved in LiDAR. They're involved in AI. They're involved in semiconductor R&D,

The fact that you have companies that are basically like the Intels or even the Fords or the Teslas of the world doing many different parts of logistics and components, I think is deeply, deeply impressive. And I could see them being extremely competitive outside of China in other countries outside of the U.S. Obviously, the U.S. will continue to have restrictions.

on China, but I could see definitely more upside for these companies like BYD moving forward. And to your point, Scott, if you look at the forward multiples, I was looking at it today on Chinese companies, they're around 12, still very low by historical standards and much lower than Japan and India. I could see a lot of upside in Chinese tech companies moving forward. Last question from me, Alice, sort of similar to Scott's question. The predominant theme so far this year has been basically

sell America question mark and that's sort of the economic geopolitical markets question every investor is asking this year and it just you know brings up this question like how is the world order going to shape up and how do the tariffs going up and then coming down affect all of that given everything you've seen this year the election the tariffs the fact that the tariffs just came down what's happening in the markets if you had to put your money on one country

and we'll call it over the course of like 20 years, between America and China, which country would you bet on? Well, at the risk of being facetious, Ed, can I say Chimerica, if that country still exists? Yes, okay. Because the two, again, back to this relationship in which they...

just reinforce each other because one side's strengths is the other side's flaws. When I think about Chinese tech manufacturing capacity, China is undoubtedly the leader and I think it will continue to be so. Basically, it's astounding that China has quietly met or even surpassed all of its Made in China 2025 goals, even though it's not talking about it anymore. I remember back in the day in Tribal 1, where there was a huge backlash, China silently achieved many of those goals.

And meanwhile, in the U.S., I still think that the U.S. has a degree of exorbitant privilege. It's going to be very hard to fully rotate out of the U.S. The fact that stocks now, the S&P, are above April the 2nd and maybe even will come up to an all-time year-to-date high suggests that people are trying to get back into the U.S.,

It's not fully convinced that this is the end of US hegemony and that there's still an appetite for US assets. I'm still bullish long-term about the US in terms of its knowledge economy, in terms of immigration.

What it gets its act together like with the COVID vaccine, it does it very, very well. And again, remains a strong consumer-driven economy in the way that China isn't. So at the risk again of sounding facetious, I would say I'd put my money on China America. It's hard to see any other economy, even EU, competing with that. I think the Europeans, even although people were saying buy Europe,

earlier this year, faced a big hurdle with Merz's fiasco. You know, he finally got elected, but it showed underlying weakness in Europe. And I think Europe is next when it comes to tariffs. So I would say Chimerica if that's at all possible. Oh,

That works for me. Alice is a China economist and director at Greenmantle, a global macro and geopolitical risk advisory company. She graduated in history and economics from Harvard and holds a master's in East Asian studies from Stanford University, where she focused on Chinese political economy and fintech. Alice?

Always learn so much from you. Thank you for joining us. Alice, just one quick thing. I think it's really important to point out that we discovered you. We discovered you. I know. I was going to say.

Can I make that publicly known somewhere? I've got so much. I'm against the digital equivalent of fan mail on LinkedIn and whatnot. Thanks to you guys. So I really appreciate that. Where I'm headed with this is when Ed needs a job and Scott needs help finding a nursing home. Remember, we discovered...

Alice Hahn. Lily, your views. We have these like old white guys with all these credentials on the pod. They get like 15,000 views and Alice Hahn comes on and you get 200,000 views. No, but I thank you guys. I mean, I'm used to being in the rooms with old white men who are twice my age. It's the norm now. It's the norm. Yeah. Anyways, congrats on all your success and thanks for your great work on this show. Yeah. Thanks so much, guys. Appreciate it.

This episode was produced by Claire Miller and engineered by Benjamin Spencer. Our associate producer is Alison Weiss. Mia Silverio is our research lead. Isabella Kinsel is our research associate. Dan Chalan is our intern. Drew Burrows is our technical director. And Catherine Dillon is our executive producer. Thank you for listening to Property Markets from the Vox Media Podcast Network. If you liked what you heard, give us a follow and join us for a fresh take on markets on Monday.